Keywords: ACR; American College of Rheumatology; bDMARDs; biologic disease-modifying antirheumatic drugs; DMARDs; disease-modifying antirheumatic drugs; EULAR; European League Against Rheumatism; GRAPPA; Group for Research and Assessment of Psoriasis and Psoriatic
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: CBC; Complete blood count; EMA; European Medicines Agency; FDA; US Food and Drug Administration; IL; Interleukin; JIA; Juvenile idiopathic arthritis; LFT; Liver function testing; MAS; Macrophage activation syndrome; SLE; Systemic lupus erythematosus; SQ;
Keywords: TNFi; TNFi cost; treatment pattern; ulcerative colitis;
Keywords: AS; ankylosing spondylitis; ASAS; Assessment of SpondyloArthritis international Society; AxSpA; axial spondyloarthritis; CRP; C-reactive protein; HLA-B27; human leukocyte antigen B27; IBD; inflammatory bowel disease; IBP; inflammatory back pain; MRI; magn
Keywords: biologic; hematologic cancer; malignancy; melanoma; phototherapy; psoriasis; topical therapy; CCI; Charlson comorbidity index; CI; confidence interval; HR; hazard ratio; IL; interleukin; KPSC; Kaiser Permanente Southern California; PUVA; psoralen plus ult
Keywords: Biologic agents; adverse effect; infection; autoimmunity; paradoxical inflammation; ANA; Antinuclear antibody; AS; Ankylosing spondylitis; DMARD; Disease-modifying antirheumatic drug; IBD; Inflammatory bowel disease; ILD; Interstitial lung disease; NTM; N
Differential Drug Survival of Second-Line Biologic Therapies in Patients with Psoriasis: Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)
Keywords: AE; adverse event; BADBIR; British Association of Dermatologists Biologic Interventions Register; CI; confidence interval; HR; hazard ratio; PASI; Psoriasis Area and Severity Index; TNFI; tumor necrosis factor inhibitors;
Risk of Serious Infection in Patients with Psoriasis Receiving Biologic Therapies: AÂ Prospective Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)
Keywords: BADBIR; British Association of Dermatologists Biologic Interventions Register; CI; confidence interval; HR; hazard ratio; IQR; interquartile range; PSOLAR; Psoriasis Longitudinal Assessment and Registry; TNFI; tumor necrosis factor inhibitor;
The risk of cardiovascular events in psoriasis patients treated with tumor necrosis factor-α inhibitors versus phototherapy: An observational cohort study
Keywords: cardiovascular event; cumulative exposure; myocardial infarction; phototherapy; psoriasis; stroke; transient ischemic attack; tumor necrosis factor-α inhibitors; unstable angina; CCI; Charlson comorbidity index; CV; cardiovascular; ICD-9; International
Cardiovascular event risk assessment in psoriasis patients treated with tumor necrosis factor-α inhibitors versus methotrexate
Keywords: psoriasis; cardiovascular event risk; methotrexate; tumor necrosis factor-α inhibitors; myocardial infarction; stroke; transient ischemic attack; unstable angina; CI; confidence interval; CST; conventional systemic therapies; CV; cardiovascular; HIPAA; H